000			01998 a2200541 4500
005			20250515174631.0
264		0	_c20090928
008			200909s 0 0 eng d
022			_a1557-8852
024	7		_a10.1089/cbr.2008.0577 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, Meili
245	0	0	_aPreclinical evaluation of an anti-CD25 monoclonal antibody, 7G7/B6, armed with the beta-emitter, yttrium-90, as a radioimmunotherapeutic agent for treating lymphoma. _h[electronic resource]
260			_bCancer biotherapy & radiopharmaceuticals _cJun 2009
300			_a303-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _ximmunology
650	0	4	_aAntibodies, Monoclonal, Humanized
650	0	4	_aAntibody Specificity _ximmunology
650	0	4	_aCell Line, Tumor
650	0	4	_aDaclizumab
650	0	4	_aDisease-Free Survival
650	0	4	_aEndocytosis _ximmunology
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunoglobulin G _xmetabolism
650	0	4	_aImmunosuppressive Agents _xmetabolism
650	0	4	_aInterleukin-2 Receptor alpha Subunit _ximmunology
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLymphoma _xpathology
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aRadioimmunotherapy _xmethods
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aYttrium Radioisotopes _xtherapeutic use
700	1		_aYao, Zhengsheng
700	1		_aGarmestani, Kayhan
700	1		_aYu, Sarah
700	1		_aGoldman, Carolyn K
700	1		_aPaik, Chang H
700	1		_aBrechbiel, Martin W
700	1		_aCarrasquillo, Jorge A
700	1		_aWaldmann, Thomas A
773	0		_tCancer biotherapy & radiopharmaceuticals _gvol. 24 _gno. 3 _gp. 303-9
856	4	0	_uhttps://doi.org/10.1089/cbr.2008.0577 _zAvailable from publisher's website
999			_c18956339 _d18956339